Surface Oncology Inc expected to post a loss of 28  cents a share - Earnings Preview

Surface Oncology

29/04/2022 19:32

* Surface Oncology Inc  SURF.OQ   SURF.O  is expected
to show a
rise in quarterly revenue when it reports  results on May 3
(estimated). 
    * The Cambridge Massachusetts-based  company is expected to
report
 a 544.7% increase in revenue to $10.483 million from $1.63
million a year ago, according to the mean estimate from 6
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Surface Oncology
Inc is
for a loss of 28 cents per share. For the same quarter last
year, the company reported a loss of 37 cents per share.
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 6 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Surface
Oncology
Inc is $12​, above​ its last closing price of $2.13. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2021  -0.15       -0.15      -0.52     Missed  -242.8
 Sep. 30 2021  -0.40       -0.40      -0.44     Missed  -9.1
 Jun. 30 2021  -0.35       -0.35      -0.44     Missed  -24.5​
 Mar. 31 2021  -0.41       -0.41      -0.37     Beat    9.3
 ​​Dec.        0.41        0.22       1.56      Beat    615.6
 31 2020                                                
 Sep. 30 2020  -0.39       -0.39      -0.39     Met     1​
 Jun. 30 2020  -0.48       -0.48      -0.44     Beat    9
 Mar. 31 2020  0.40        0.43       0.74      Beat    73.4
 This summary was machine generated April 29 at 18:31 GMT.  All
figures in US dollars  unless otherwise stated